Food and Drug Administration News and Analysis | GovernmentCIO Media & Research

Food and Drug Administration News and Analysis

News and updates covering the U.S. Food and Drug Administration. As the agency tasked with regulating the safety of medical devices and pharmaceutical products, the FDA has sought to embrace the efficiencies provided by digital modernization. This has included a special focus on incorporating AI and machine-learning capacities toward drug development and pharmaceutical research, as well as the FDA’s ongoing research and development into applying technologies like 3D printing toward manufacturing medical supplies amid the COVID-19 epidemic.
The acting CIO shared insights into the agency's pandemic response and lessons learned so far.
The group will consolidate data and resources to research and develop COVID-19 pharmaceutical solutions.
Technological solutions could provide relief to medical facilities in urgent need of necessary equipment.
The technology is one way to solve national shortages of medical supplies during the COVID-19 pandemic.
The molecular diagnostics test is the fastest test for the novel coronavirus in the U.S.
Global health leaders are calling attention to the world's other leading infectious diseases like tuberculosis.
Data can accelerate the approval processes for new drugs and medical devices.
A GAO report highlights policy areas as the FDA considers regulatory rules around the technology.
Agencies find opportunity in increasing diversity within cyber programs and leveraging shared services.
Health agencies point to a need for modernized IT infrastructure and data-driven decisions.
The emerging technologies can predict, anticipate and protect against dangerous chemicals in the U.S. food supply.
The center uses significant data processes and analytics in the effort to curb tobacco-related disease and death.
The Digital Health Pre-Cert Pilot Program continues despite commissioner's recent resignation announcement.
Companies are deploying artificial intelligence without standardized ethics or measured implications.
By all assessments, artificial intelligence has a bright future in health care.
It can't offer a soothing smile or strike an inspirational doctor pose, but it can help improve recovery.
But it can’t be scaled without “a vote of confidence that it protects and promotes patients."
Leveraging the cloud is also part of FDA’s strategic plan.
And next year’s goals include stronger interoperability, APIs and microservices